E

Epsilon Healthcare Ltd
ASX:EPN

Watchlist Manager
Epsilon Healthcare Ltd
ASX:EPN
Watchlist
Price: 0.034 AUD 6.25% Market Closed
Market Cap: 12.9m AUD

Relative Value

EPN doesn't have a meaningful market cap.

The Relative Value of one EPN stock under the Base Case scenario is hidden AUD. Compared to the current market price of 0.034 AUD, Epsilon Healthcare Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

EPN Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
27
vs Industry
66
Median 3Y
1.5
Median 5Y
1.5
Industry
2.6
vs History
vs Industry
Median 3Y
-1.5
Median 5Y
-1.5
Industry
21.4
vs History
vs Industry
Median 3Y
-4.4
Median 5Y
-4
Industry
16.4
vs History
vs Industry
Median 3Y
-1.3
Median 5Y
-1.8
Industry
22.8
vs History
vs Industry
58
Median 3Y
0.7
Median 5Y
0.8
Industry
2.2
vs History
19
vs Industry
56
Median 3Y
2
Median 5Y
2.4
Industry
2.9
vs History
33
vs Industry
66
Median 3Y
3.5
Median 5Y
5.2
Industry
5.5
vs History
vs Industry
Median 3Y
-3
Median 5Y
-2.9
Industry
13
vs History
vs Industry
Median 3Y
-3
Median 5Y
-2.9
Industry
16.5
vs History
vs Industry
Median 3Y
-7.1
Median 5Y
-4.3
Industry
15.6
vs History
vs Industry
Median 3Y
-7.1
Median 5Y
-4.2
Industry
18.7
vs History
0
vs Industry
60
Median 3Y
1
Median 5Y
0.9
Industry
1.9

Multiples Across Competitors

EPN Competitors Multiples
Epsilon Healthcare Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Epsilon Healthcare Ltd
ASX:EPN
11.9m AUD 2.1 -2.1 -3.4 -3.4
US
Eli Lilly and Co
NYSE:LLY
1T USD 17.2 55.5 37.2 39.9
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
498.9B USD 5.4 19.9 16.2 21.1
CH
Roche Holding AG
SIX:ROG
259.1B CHF 4.2 27.5 11.7 13.7
UK
AstraZeneca PLC
LSE:AZN
208.8B GBP 4.8 30 108.3 158.5
US
Merck & Co Inc
NYSE:MRK
264.8B USD 4.1 13.9 9.9 11.7
CH
Novartis AG
SIX:NOVN
207.2B CHF 4.7 18.2 11.5 14.9
DK
Novo Nordisk A/S
CSE:NOVO B
1.5T DKK 4.8 14.5 10.1 11.7
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
143.2B USD 2.3 14.6 7.4 10.2
P/E Multiple
Earnings Growth PEG
AU
E
Epsilon Healthcare Ltd
ASX:EPN
Average P/E: 24.2
Negative Multiple: -2.1
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
55.5
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.9
29%
0.7
CH
Roche Holding AG
SIX:ROG
27.5
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
30
37%
0.8
US
Merck & Co Inc
NYSE:MRK
13.9
15%
0.9
CH
Novartis AG
SIX:NOVN
18.2
17%
1.1
DK
Novo Nordisk A/S
CSE:NOVO B
14.5
3%
4.8
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.6
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
AU
E
Epsilon Healthcare Ltd
ASX:EPN
Average EV/EBITDA: 439.7
Negative Multiple: -3.4
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
37.2
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.2
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.7
5%
2.3
UK
AstraZeneca PLC
LSE:AZN
108.3
10%
10.8
US
Merck & Co Inc
NYSE:MRK
9.9
6%
1.6
CH
Novartis AG
SIX:NOVN
11.5
6%
1.9
DK
Novo Nordisk A/S
CSE:NOVO B
10.1
1%
10.1
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.4
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
AU
E
Epsilon Healthcare Ltd
ASX:EPN
Average EV/EBIT: 1 883.3
Negative Multiple: -3.4
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39.9
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.1
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.7
6%
2.3
UK
AstraZeneca PLC
LSE:AZN
158.5
23%
6.9
US
Merck & Co Inc
NYSE:MRK
11.7
8%
1.5
CH
Novartis AG
SIX:NOVN
14.9
12%
1.2
DK
Novo Nordisk A/S
CSE:NOVO B
11.7
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
7%
1.5